Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $42.32 USD
Change Today -0.39 / -0.91%
Volume 3.3M
ZTS On Other Exchanges
New York
As of 8:04 PM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

zoetis inc (ZTS) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/25/15 - $55.38
52 Week Low
10/15/14 - $34.16
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ZOETIS INC (ZTS)

zoetis inc (ZTS) Details

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. The company operates through four segments: the United States; Europe/Africa/Middle East; Canada/Latin America; and Asia/Pacific. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines that are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The company also provides medicated feed additives that offer medicines to livestock; veterinarian solutions for anesthesia and treating pain and serious illnesses, such as diabetes; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. In addition, it offers other product categories, such as nutritionals and agribusiness, as well as products and services in complementary areas, including diagnostics, genetics, biodevices, and services. The company markets its products to veterinarians and livestock producers through its sales representatives, and technical and veterinary operations specialists. Zoetis Inc. was founded in 1952 and is headquartered in Florham Park, New Jersey.

10,000 Employees
Last Reported Date: 02/27/15
Founded in 1952

zoetis inc (ZTS) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $1.1M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $207.6K
Executive Vice President and President of U.S...
Total Annual Compensation: $620.4K
Executive Vice President and President of Int...
Total Annual Compensation: $451.4K
President of Research & Development and Execu...
Total Annual Compensation: $451.4K
Compensation as of Fiscal Year 2014.

zoetis inc (ZTS) Key Developments

Zoetis Inc. Declares Fourth Quarter 2015 Dividend, Payable on Dec. 1, 2015

The Board of Directors of Zoetis Inc. has declared a fourth quarter 2015 dividend payable to holders of the company’s common stock of $0.083 per share. The dividend is to be paid on Dec. 1, 2015, to holders of record on Nov. 5, 2015.

Zoetis Inc. Completes Manufacturing Facility Expansion in Lincoln, Nebraska

Zoetis Inc. has completed a 19,000sqft, three-story expansion at its manufacturing facility in Lincoln, Nebraska. With the expansion, as many as 30 new positions could be added at peak production time. Zoetis produces some of its pharmaceutical products and vaccines at the Lincoln plant, including BOVI-SHIELD GOLD and RESPISURE ONE for livestock and RIMADYL (carprofen) for dogs. The expansion will also facilitate the full production of SYNOVEX, a product that helps increase weight gain and improve feed efficiency in beef cattle.

Zoetis Inc. Presents at Morgan Stanley Global Healthcare Conference - New York, Sep-18-2015 01:35 PM

Zoetis Inc. Presents at Morgan Stanley Global Healthcare Conference - New York, Sep-18-2015 01:35 PM. Venue: The Grand Hyatt New York, 109 East 42nd Street, New York, New York, United States. Speakers: Kristin C. Peck, Executive Vice President and President of U.S. Operations, Paul S. Herendeen, Chief Financial Officer and Executive Vice President.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZTS:US $42.32 USD -0.39

ZTS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abaxis Inc $44.96 USD -0.70
IDEXX Laboratories Inc $72.74 USD -2.47
Phibro Animal Health Corp $31.45 USD -0.21
Vetoquinol SA €40.90 EUR 0.00
Virbac SA €159.55 EUR -1.00
View Industry Companies

Industry Analysis


Industry Average

Valuation ZTS Industry Range
Price/Earnings 51.1x
Price/Sales 4.4x
Price/Book 18.1x
Price/Cash Flow 44.4x
TEV/Sales 3.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZOETIS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at